Advertisement

PRLD

Prelude Therapeutics Incorporated

Healthcare · USD

Set alert

Price alert · PRLD

All alert types
3.88 USD -0.22 -5.37%
As of Oct 30, 2026 Extended hours 3.85 -0.77%
Bid
3.88 × 2
Ask
3.89 × 2
3.82 Day range 4.11
1.19 52-week range 6.63
YTD
+33.79%
1 year
+147.13%
Open
4.01
Prev close
4.10
Mkt cap
309.02M
Vol
218.10K
Avg vol
494.54K
EPS
-0.73
P/E
0.00
Div yield
0.00%
More statistics
Low
3.82
High
4.11
Forward P/E
-0.82
Beta
1.55
Short ratio
7.51
Inst. own
84.98%
Dividend
0.00
Ex-div date
Earnings
Aug 12, 2024
50-d avg
1.23
200-d avg
3.50
1y target
5.00

5D chart

Chart tools
Interval
PRLD five-day price chart3.403.613.834.044.25Oct 26Oct 27Oct 28Oct 29Oct 30

Peers

Companies in the same industry

PRLD peers
SymbolNameLastChangeChange %YTDMarket cap
DRNADicerna Pharmaceuticals, Inc.38.220.000.00%—2.98B
KYMRKymera Therapeutics, Inc.126.63+4.03+3.29%+62.74%10.81B
DCPHDeciphera Pharmaceuticals, Inc.25.590.000.00%—2.21B
MGNXMacroGenics, Inc.2.40+0.02+0.84%+49.07%152.88M
MCRBSeres Therapeutics, Inc.1.77-0.18-9.23%-88.10%17.78M
RVNCRevance Therapeutics, Inc.3.650.000.00%+20.07%320.48M
QTRXQuanterix Corporation2.91-0.24-7.63%-54.32%137.39M
FGENFibroGen, Inc.9.070.000.00%+3.30%48.37M
BLUEbluebird bio, Inc.4.970.000.00%-40.41%75.74M
NGMNGM Biopharmaceuticals, Inc.1.540.000.00%—128.53M
Advertisement